Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Molecular epidemiological characteristics of Mycobacterium leprae in highly endemic areas of China during the COVID-19 epidemic

Zhou J, Wu Z, Tong Y, et al. Frontiers Media SA. Frontiers in Public Health. 2024;
Download PDF
Publication

Bacilloscopy for leprosy in Brazil's public health system between 2013 and 2022

Barbosa-Lima R, Vivian GF, Alba LMR, et al. Revista Ciencias em Saude. REVISTA CIÊNCIAS EM SAÚDE. 2023; 13 (4) : 38-45.
Download PDF
Publication

Living with hanseníase: experiences, meanings and perceptions

Pereira Lima V, De Araujo Soares V, D' `Paula Ribeiro Vieira Torres J, et al. Periodicojs. Health and Society. 2024; 4 (01) : 139-155.
Download PDF
Publication

Participatory Development and Assessment of Audio-Delivered Interventions and Written Material and Their Impact on the Perception, Knowledge, and Attitudes Toward Leprosy in Nigeria: Protocol for a Cluster Randomized Controlled Trial.

Murphy-Okpala N, Dahiru T, Noordende A, et al. JMIR research protocols. 2024;
Download PDF
Publication

Large-scale epidemiological analysis of common skin diseases to identify shared and unique comorbidities and demographic factors.

Li Q, Patrick M, Sreeskandarajan S, et al. Frontiers in immunology. 2023;
Download PDF
Publication

Description of electroneuromiographic and laboratorial findings in leprosy neuropathy, according to its clinical forms: the confirmation of a spectral disease.

Santos D, Borges I, Garcia L, et al. Frontiers in medicine. 2023;
Download PDF
Publication

Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine.

Matono T, Suzuki S, Mori S, et al. The American journal of tropical medicine and hygiene. 2024;
Download PDF
Publication

Identification of gene signatures and molecular mechanisms underlying the mutual exclusion between psoriasis and leprosy.

Lu Y, Dong R, Yang L, et al. Scientific reports. 2024; 14 (1) : 1-13.
Download PDF
Publication

Borderline Lepromatous Leprosy with Mild Reversal Reaction in Child

Fonna N, Ariani T, Rizal Y, et al. Frontiers in Healthcare Research. 2024; 1 (1) : 1-5.
Download PDF
Publication

A case report of borderline lepromatous leprosy: a neglected tropical disease that impairs quality of life

Rusyati L. M. M, Mahariski P. A, Karmila G. A. A. D, et al. Bali Medical Journal. 2024; 13 (1) : 527-530.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 126
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD